In June 2022 a cluster of two cases of Candida pelliculosa osteoarticular infections was identified among patients who received joint injections at an outpatient facility. Isolate whole-genome sequencing analysis, combined with infection prevention and control observations at the facility suggested a common source of infection, potentially from extrinsically contaminated medication.